Proteogenomic Characterization Reveals Therapeutic Vulnerabilities in Lung Adenocarcinoma

Cited by (846)

Items 401–500 of 846

1. Integrative proteomic characterization of human lung adenocarcinoma with KRAS G12 mutations reveals molecular pathogenesis
   Shi, Xinyu, Hu, Liling, Huang, Yongshi, Zhang, Mei-Fang, Ying, Xingfeng, Yuan, Xiaoyi, Wen, Nengqiao, Lu, Jiangli, Zou, Hanchen, Tan, Xiaohui et al. · 2026 · Journal of Advanced Research
2. Blood proteomics for quantitative biomarkers of cellular therapies
   Philip R. Gafken, Sophie Paczesny · 2025 · Biomarker Research
3. New genomic and proteomic biomarker discovery in cancer: revolutionizing diagnosis and prognostication
   Monika Rajput, Manoj Pandey, Ruhi Dixit · 2026 · World Journal of Surgical Oncology
4. The Potential Prognostic Role of Oligosaccharide-Binding Fold-Containing Protein 2A (OBFC2A) in Triple-Negative Breast Cancer
   Qianxue Wu, Xin-Ming Tang, Wenming Zhu, Qing Li, Xiang Zhang, Hong-Yuan Li · 2021 · Frontiers in Oncology
5. An overview of multiomics: a powerful tool applied in cancer molecular subtyping for cancer therapy
   Yazhu Zou, Zitong Zhao, Yongmei Song · 2023 · Malignancy Spectrum
6. Proteome Analysis Related to Unsaturated Fatty Acid Synthesis by Interfering with Bovine Adipocyte ACSL1 Gene
   Yanbin Bai, Jingsheng Li, Yali Wei, Zongchang Chen, Zhanxin Liu, Dashan Guo, Xue Jia, Yanmei Niu, Bingang Shi, Xiaolan Zhang et al. · 2024 · Antioxidants
7. Proteogenomic Insights Into Glioblastoma Evolution: Neuronal Reprogramming and Therapeutic Vulnerabilities
   Harim Koo, Jason K. Sa · 2025 · Brain Tumor Research and Treatment
8. A Microarray Study on the Expression of ANKRD49 in Lung Squamous Cell Carcinoma and Its Clinicopathologic Significance
   Xinyang Li, Keru Qin, Yuehua Liu, Min Pang, Yun-kui Huo, Baofeng Yu, Hailong Wang · 2022 · Applied immunohistochemistry & molecular morphology
9. The Association of R-Loop Binding Proteins Subtypes with CIN Implicates Therapeutic Strategies in Colorectal Cancer
   Wenchao Zhao, Qian Pei, Yongwei Zhu, Dongdong Zhan, Guo Mao, Meng Wang, Yanfang Qiu, Ke Zuo, Haiping Pei, Lun‐Quan Sun et al. · 2022 · Cancers
10. HNRNPA2B1 as a potential therapeutic target for thymic epithelial tumor recurrence: An integrative network analysis
    Ziyun Zhou, Yu Lu, Zhitao Gu, Qiangling Sun, Wentao Fang, Wei Yan, Xin Ku, Zhongjie T. Liang, Guang Hu · 2023 · Computers in Biology and Medicine
11. A multiplexed assay for quantifying immunomodulatory proteins supports correlative studies in immunotherapy clinical trials
    Jeffrey R. Whiteaker, Lei Zhao, Regine M. Schoenherr, Dongqing Huang, Rachel A. Lundeen, Uliana J. Voytovich, Jacob J. Kennedy, Richard G. Ivey, Chenwei Lin, Oscar D. Murillo et al. · 2023 · Frontiers in Oncology
12. Tumor-infiltrating Leukocyte Profiling Defines Three Immune Subtypes of NSCLC with Distinct Signaling Pathways and Genetic Alterations
    Kazunori Aoki, Yukari Nishito, Noriko Motoi, Yasuhito Arai, Nobuyoshi Hiraoka, Tatsuhiro Shibata, Yukiko Sonobe, Yoko Kayukawa, Eri Hashimoto, Mina Takahashi et al. · 2023 · Cancer Research Communications
13. Unbiased differential proteomic profiling between cancer-associated fibroblasts and cancer cell lines
    Rachel Lau, Lu Yu, Theodoros I. Roumeliotis, Adam R. Stewart, Lisa Pickard, Ruth Riisanes, Bora Gürel, Johann Sebastian De Bono, Jyoti Sharma Choudhary, Udai Banerji · 2023 · Journal of Proteomics
14. Multiplexed Quantitative Proteomics Reveals Proteomic Alterations in Two Rodent Traumatic Brain Injury Models
    Junho Park, Seung Hak Lee, Dongyoon Shin, Yeongshin Kim, Young Sik Kim, Min Yong Seong, Jin Joo Lee, Han Gil Seo, Won‐Sang Cho, Young Sun Ro et al. · 2023 · Journal of Proteome Research
15. Polypeptide N-acetylgalactosaminyltransferase 18 retains in endoplasmic reticulum depending on its luminal regions interacting with ER resident UGGT1, PLOD3 and LPCAT1
    Wenjuan Jia, Xia Zou, Zhijue Xu, Lin Bai, Aidong Shan, Yankun Li, Jingjing Shi, Fang Yang, Chen Ding, Hisashi Narimatsu et al. · 2021 · Glycobiology
16. Somatic mutation subtypes of lung adenocarcinoma in East Asian reveal divergent biological characteristics and therapeutic vulnerabilities
    Wai-Kok Choong, Ting‐Yi Sung · 2021 · iScience
17. Protein-gene Expression Nexus: Comprehensive characterization of human cancer cell lines with proteogenomic analysis
    Daejin Hyung, Min-Jeong Baek, Jongkeun Lee, Ju‐Yeon Cho, Hyoun Sook Kim, Charny Park, Soo Young Cho · 2021 · Computational and Structural Biotechnology Journal
18. Individualized Proteogenomics Reveals the Mutational Landscape of Melanoma Patients in Response to Immunotherapy
    Marisa Schmitt, Tobias W. Sinnberg, Heike Niessner, Andrea Forschner, Claus Garbe, Boris Maček, Nicolas Nalpas · 2021 · Cancers
19. NcRNA-regulated CAPZA1 associated with prognostic and immunological effects across lung adenocarcinoma
    Tingting Qin, Wanping Xiang, Yiming Mao, Hongyan Zhai, Zhihao Yang, Hongpan Zhang · 2023 · Frontiers in Oncology
20. Investigative needle core biopsies for multi-omics in Glioblastoma
    Kenny Kwok Hei Yu, Sreyashi Basu, Gerard Baquer, Ryuhjin Ahn, Jennifer K. Gantchev, Sonali Jindal, Michael Scott Regan, Zaki Abou-Mrad, Michael C. Prabhu, Marc J. Williams et al. · 2023 · medRxiv
21. Integrated multi-omics analysis for lung adenocarcinoma in Xuanwei, China
    Jiang, Boyi, Yang, Jiapeng, He, Rui, Wang, Dong, Huang, Yunchao, Zhao, Guangqiang, Ning, Mingjie, Zeng, Teng, Li, Guangjian · 2023 · Aging
22. RAD21-mediated epigenetic regulation promotes lung adenocarcinoma progression and sensitizes cancer cells to ERK-targeted therapy
    Chu Xiao, Tao T. Fan, Di Wang, Hong Yin, Ziqin Deng, Wenpeng Cai, Yu Ji, Yixiao Liu, Jia Li, Tianle Liao et al. · 2025 · Cancer Letters
23. Functional landscape of ubiquitin linkages couples K29-linked ubiquitylation to epigenome integrity
    Javier Arroyo-Gomez, Matthew J Murray, Claire Guérillon, Juanjuan Wang, Ekaterina A. Isaakova, Nazaret Reverón-Gómez, Mikaela Koutrouli, Aldwin Suryo Rahmanto, Katrine Mitrofanov, Andreas Ingham et al. · 2025 · The EMBO Journal
24. Mass Spectrometry Proteomics: A Key to Faster Drug Discovery
    Lorenzo Tagliazucchi, Maria Paola Costi · 2025 · Journal of Medicinal Chemistry
25. Multi-omics signatures of chronic inflammation across immune-related disease states
    Hui Li, Xiaolin Xie, Lirui Tang, Chuanben Chen, Jinluan Li · 2026 · Frontiers in Immunology
26. Dynamic transcriptome, proteome, and A-to-I editome are associated with temperature adaptation in the highly invasive lace bug
    Yuange Duan, Tianyou Zhao, Qiuhua Xie, Zhenyong Du, Ling Ma, Jiyao Liu, Maowen Wang, Fan Song, Li Tian, Wanzhi Cai et al. · 2026 · Chemical Engineering Journal
27. Potential of lncRNAs to regulate cuproptosis in hepatocellular carcinoma: Establishment and validation of a novel risk model
    Jing He, Weiqi Li, Weijun Zhao, Hao Shen, Yushun Chang, Boqiang Liu, Qiang He, Hong Yu, Yifan Wang, Liang Shi et al. · 2024 · Heliyon
28. Identification and role of differentially expressed genes/proteins between pulmonary tuberculosis patients and controls across lung tissues and blood samples
    Qifeng Li, Maierheba Kuerbanjiang · 2024 · Immunity Inflammation and Disease
29. SiRCle (Signature Regulatory Clustering) model integration reveals mechanisms of phenotype regulation in renal cancer
    Ariane Mora, Christina Schmidt, Brad Balderson, Christian Frezza, Mikael Bodén A · 2024 · Genome Medicine
30. DDX47 promotes cell proliferation and migration in lung adenocarcinoma
    Yang Chen, Lizhong Zeng, Wei Wang, Jingyan Yuan, Ruiying Sun, Shuanying Yang · 2022 · Pathology - Research and Practice
31. SMEK1 promotes lung adenocarcinoma proliferation and invasion by activating Wnt/β-catenin signaling pathway
    Dandan Chen, Shang Gao, Fei Gao, Ai Liu, Jiangxia Li, Qiji Liu, Qiji Liu · 2022 · Clinical & Translational Oncology
32. Longitudinal Plasma Proteomics-Derived Biomarkers Predict Response to MET Inhibitors for MET-Dysregulated NSCLC
    Guang‐Ling Jie, Lun-Xi Peng, Mei-Mei Zheng, Hao Sun, Song-Rong Wang, Si‐Yang Maggie Liu, Kai Yin, Zhihong Chen, Hong‐Xia Tian, Jin‐Ji Yang et al. · 2023 · Cancers
33. Quantitative Proteomic and Phosphoproteomic Profiling of Lung Tissues from Pulmonary Arterial Hypertension Rat Model
    Ang Luo, Yangfan Jia, Rongrong Hao, Yafang Yu, Xia Zhou, Chenxin Gu, Meijuan Ren, Haiyang Tang · 2023 · International Journal of Molecular Sciences
34. Development and Validation of txSim: A Model of Advanced Lung Cancer Treatment in Australia
    Preston Ngo, Deme John Karikios, David Eamon Goldsbury, Stephen L. Wade, Zarnie Lwin, Brett G.M. Hughes, Kwun Meng Fong, Karen Canfell, Marianne Frances Weber · 2023 · PharmacoEconomics
35. Spatially Resolved Proteomic and Transcriptomic Profiling of Anaplastic Lymphoma Kinase-Rearranged Pulmonary Adenocarcinomas Reveals Key Players in Inter- and Intratumoral Heterogeneity
    Beáta Szeitz, Tibor Glasz, Zoltán Herold, Gábor Tóth, Mirjam Balbisi, János Fillinger, Szabolcs Horváth, Réka Mohácsi, Ho Jeong Kwon, Judit Moldvay et al. · 2023 · International Journal of Molecular Sciences
36. Ropivacaine inhibits the malignant behavior of lung cancer cells by regulating retinoblastoma-binding protein 4
    Weiai Jia, Junmei Shen, Sisi Wei, Chao Li, Jingpu Shi, Lianmei Zhao, Huiqun Jia · 2023 · PeerJ
37. Surrogate Biomarker Prediction from Whole-Slide Images for Evaluating Overall Survival in Lung Adenocarcinoma
    Pierre Murchan, Anne‐Marie Baird, Pilib Ó Broin, Orla M. Sheils, Stephen P. Finn · 2024 · Diagnostics
38. A Comprehensive Evaluation Framework for Benchmarking Multi-Objective Feature Selection in Omics-Based Biomarker Discovery
    Luca Cattelani, Arindam Ghosh, Teemu Rintala, Vittorio Fortino · 2024 · IEEE Transactions on Computational Biology and Bioinformatics
39. Melanoma Proteomics Unveiled: Harmonizing Diverse Data Sets for Biomarker Discovery and Clinical Insights via MEL-PLOT
    Áron Bartha, Boglárka Weltz, Lazaro Hiram Betancourt, Jeovanis Gil, Natália Pinto de Almeida, Giampaolo Bianchini, Beáta Szeitz, Letícia Szadai, Indira Plá, Lajos Vince Kemény et al. · 2025 · Journal of Proteome Research
40. Protein Complex Organization Imposes Constraints on Proteome Dysregulation in Cancer
    Gökçe Senger, Martin H. Schaefer · 2021 · Frontiers in Bioinformatics
41. The Predictive Role of Immune Related Subgroup Classification in Immune Checkpoint Blockade Therapy for Lung Adenocarcinoma
    Xiaozhou Yu, Ziyang Wang, Yiwen Chen, Guotao Yin, Jianjing Liu, Wei Chen, Lei Zhu, Wengui Xu, Xiaofeng Li · 2021 · Frontiers in Genetics
42. Gene expression profiling using targeted RNA-sequencing to elucidate the progression from histologically normal lung tissues to non-invasive lesions in invasive lung adenocarcinoma
    Taichi Kadonaga, Tomohiko Sakabe, Yoshiteru Kidokoro, Tomohiro Haruki, Kanae Nosaka, Hiroshige Nakamura, Yoshihisa Umekita · 2022 · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin
43. Industrialized, Artificial Intelligence-guided Laser Microdissection for Microscaled Proteomic Analysis of the Tumor Microenvironment
    Dave Mitchell, Allison L. Hunt, Kelly A. Conrads, Brian L. Hood, Sasha C. Makohon‐Moore, Christine Rojas, George Larry Maxwell, Nicholas W. Bateman, Thomas P. Conrads · 2022 · Journal of Visualized Experiments
44. TRAIP serves as a potential prognostic biomarker and correlates with immune infiltrates in lung adenocarcinoma
    Jing Yu, Ziming Mao, Jing Zhu, Xirui Ma, Huifang Liu, Fengling Chen · 2023 · International Immunopharmacology
45. Uncovering the modified immunopeptidome reveals insights into principles of PTM-driven antigenicity
    Assaf Kacen, Aaron Javitt, Matthias P. Kramer, David Morgenstern, Tomer Tsaban, Adam Solomon, Guo Ci Teo, Felipe da Veiga Leprevost, Eilon Barnea, Fengchao Yu et al. · 2021 · bioRxiv (Cold Spring Harbor Laboratory)
46. An atlas of protein-protein associations of human tissues prioritizes candidate disease genes
    Diederik S. Laman Trip, Marc van Oostrum, Danish Memon, Fabian Frommelt, Delora Baptista, Kalpana Panneerselvam, Glyn Bradley, Luana Licata, Henning Hermjakob, Sandra E. Orchard et al. · 2024 · bioRxiv (Cold Spring Harbor Laboratory)
47. Immune cell dynamics and the impact on the efficiency of transvascular antitumor interventional therapies in hepatocellular carcinoma patients
    Yuan-dong Sun, Hao Zhang, Yuanmin Li, Chunxiao Zhou, Jian-Jun Han · 2024 · Frontiers in Immunology
48. Multi-Omics Integration of Lactylation- and PANoptosis-Based Signatures in Lung Adenocarcinoma: Prognostic Stratification and Immune Response
    Zhenhao Xu, Yisha Huang, Xiuling Yu, Jiajia Xuan, Wan-Ting Liu · 2025 · International Journal of Molecular Sciences
49. Single-cell RNA sequencing reveals palmitoylation-driven cellular heterogeneity and prognostic biomarkers in lung adenocarcinoma
    Taibo Huang, Lijie Kou, Qianqian Zhang, Xueya Liu, Xingang Hu · 2025 · Translational Oncology
50. RANBP9 and RANBP10 cooperate in regulating non-small cell lung cancer proliferation
    Arturo Orlacchio, Yasuko Kajimura, Lara Rizzotto, Anna Tessari, Shimaa Hassan AbdelAziz Soliman, Rosa Visone, Liwen Zhang, Brian D. Fries, Lino Tessarollo, Joseph M. Amann et al. · 2025 · Journal of Experimental & Clinical Cancer Research
51. Proteogenomic Characterization Reveals Subtype‐Specific Therapeutic Potential for HER2‐Low Breast Cancer
    Shouping Xu, Keda Yu, Lei Liu, Qin Wang, Xiaohui Wu, Yihai Chen, Guozheng Li, Xin Zhang, Bo Wei, Zitong Fu et al. · 2025 · Advanced Science
52. Biological big data analysis in the post-genomic era: applications and limitations
    Shubham Pant, Jyoti Kant Choudhari, Rajesh Kumar Pathak, Anil Kumar Yadav, Dev Bukhsh Singh · 2026 · Network Modeling Analysis in Health Informatics and Bioinformatics
53. Strategies of AI ‐Driven CAR ‐T Cell Therapy Towards Solid Tumours
    Ahmed M. E. Abdalla, Yu Miao, Yasir A. Taha, Ning Meng, Chenxi Ouyang · 2026 · Immunology
54. Clinicogenomic analysis of EGFR -mutant lung tumors identifies Rb pathway inactivation as a hallmark of squamous transformation
    Alexandria Dymun, Mark Yungjie Jeng, Arielle Elkrief, Harshita Mehrotra, Soo‐Ryum Yang, Christina E. Wilson, Natasha Rekhtman, Irina Linkov, Amanda Pupo, Christina J. Falcon et al. · 2026 · Science Translational Medicine
55. Profiling Phosphoproteome Landscape in Circulating Extracellular Vesicles from Microliters of Biofluids through Functionally Tunable Paramagnetic Separation
    Jie Sun, Qing X. Li, Yajie Ding, Wei Dong, Marco Hadisurya, Zhuojun Luo, Zhongze Gu, Bobin Chen, W. Andy Tao · 2023 · Angewandte Chemie
56. Crosstalk among Alternative Polyadenylation, Genetic Variants and Ubiquitin Modification Contribute to Lung Adenocarcinoma Risk
    Yutong Wu, Yanqiong Yuan, Huiwen Xu, Wendi Zhang, Anhui Ning, Siqi Li, Qiong Chen, Xiaobo Tao, Gongbu Pan, Tian Tian et al. · 2024 · International Journal of Molecular Sciences
57. Depletion-dependent activity-based protein profiling using SWATH/DIA-MS detects serine hydrolase lipid remodeling in lung adenocarcinoma progression
    Tatjana Sajic, Matej Vizovišek, Stephan Arni, Rodolfo Ciuffa, Martin Mehnert, Sébastien Lenglet, Walter Weder, Héctor Gallart‐Ayala, Julijana Ivanišević, Marija Buljan et al. · 2025 · Nature Communications
58. Myeloid-Derived Growth Factor-Regulated Oncogenesis in Lung Adenocarcinoma Is Associated with EGFR Status and Cancer Aggressiveness
    Ting‐Feng Hsiao, Chih-Liang Wang, Yi‐Cheng Wu, Chia-Yu Kuo, Ke-Wei Lin, Wen‐Yu Chuang, Chi‐Ju Yeh, Chia‐Chun Wu, Ko-Jiunn Liu, Gee‐Chen Chang et al. · 2025 · Journal of Proteome Research
59. Integrative Proteogenomics and Forward Genetics Reveal a Novel Mitotic Vulnerability in Triple-Negative Breast Cancer
    Nicholas J. Neill, Shankha Satpathy, Karsten Krug, Jitendra Kumar Meena, Nivetha Ramesh Babu, Cheyenne Calderon, Desmon Reed, Marcus J. Weber, Lacey Elizabeth Dobrolecki, Alaina N. Lewis et al. · 2025 · Cancer Discovery
60. Multi-omics protein signaling networks identify sex-specific therapeutic candidates in lung adenocarcinoma
    Chen Chen, Enakshi Saha, Jonas Fischer, Marouen Ben Guebila, Viola Fanfani, Katherine Hoff Shutta, Megha Padi, Kimberly Glass, Dawn Lisa DeMeo, Camila M. Lopes‐Ramos et al. · 2025 · Biology of Sex Differences
61. Evaluation of machine learning models on protein level inference from prioritized RNA features
    Wenjian Xu, Haochen He, Zhengguang Guo, Wěi Li · 2022 · Briefings in Bioinformatics
62. iProMix: A Mixture Model for Studying the Function of ACE2 based on Bulk Proteogenomic Data
    Xiaoyu Song, Jiayi Ji, Pei Wang · 2022 · Journal of the American Statistical Association
63. Immune checkpoint therapy and response biomarkers in non-small-cell lung cancer: Serum NY-ESO-1 and XAGE1 antibody as predictive and monitoring markers
    Koji Kurose, Kanako Sakaeda, Minoru Fukuda, Yumiko Sakai, Hiroyuki Yamaguchi, Shinnosuke Takemoto, Katsuhiko Shimizu, Takeshi Masuda, Katsumi Nakatomi, Shigeo Kawase et al. · 2022 · Advances in clinical chemistry
64. Clinical, Genomic, and Transcriptomic Featurses of Lung Adenocarcinoma With Uncommon EGFR Mutation
    Kazuki Hayasaka, Haruna Takeda, Akira Sakurada, Yuki Matsumura, Jiro Abe, Satoshi Shiono, Hirotsugu Notsuda, Hiroyuki Suzuki, Makoto Endo, Hozumi Motohashi et al. · 2023 · Clinical Lung Cancer
65. Multi-omics analysis reveals PUS1 triggered malignancy and correlated with immune infiltrates in NSCLC
    Yonghuang Tan, Zhaotong Wang, Yingzhao Wang, Xiaolu Tian, Yunru Huang, Guoyong Wu, Jianjun Lu · 2023 · Aging
66. Proteomic analyses identify HK1 and ATP5A to be overexpressed in distant metastases of lung adenocarcinomas compared to matched primary tumors
    Helen Pasternack, Mirjam Polzer, Timo Gemoll, Christiane Kümpers, Thorben Sauer, Pamela Lazar‐Karsten, Sofie Hinrichs, Sabine Bohnet, Sven Perner, Franz F. Dressler et al. · 2023 · Scientific Reports
67. Mutation-guided chemotherapy-free strategy in first-line immunotherapy for low PD-L1-expressing non-squamous NSCLC
    Hui Li, Jingjing Liu, Liang Zhang, Yu Xu, Xinyue Wang, Shaowei Lan, Peng Lei Cui, Guoqiang Wang, Shangli Cai, Ying Cheng · 2024 · Journal for ImmunoTherapy of Cancer
68. Clinical perspectives on the value of testing for STK11 and KEAP1 mutations in advanced NSCLC
    Michelle Shiller, Melissa Lynne Johnson, Robert Auber, Sandip Pravin Patel · 2024 · Frontiers in Oncology
69. Proteomic-based stemness score measures oncogenic dedifferentiation and enables the identification of druggable targets
    Iga Kołodziejczak, Renan Simões, Emerson de Souza Santos, Elizabeth G. Demicco, Rossana N. Lazcano Segura, Ma Weiping, Pei Wang, Yifat Geffen, Erik P. Storrs, Francesca Petralia et al. · 2025 · Cell Genomics
70. Advancing precision antibody-drug conjugate therapy: unique proteogenomic profiles of tumor subsets in non-small cell lung cancer
    Edwin Lin, Ying‐Chun Lo, Vivek Subbiah, Rajat Thawani, Aakash P. Desai · 2025 · Experimental Hematology and Oncology
71. Across the Globe: Proteogenomic Landscapes of Lung Cancer
    Gali Arad, Tamar Geiger · 2020 · Cell
72. Proteomic Profiling Identifies Co-Regulated Expression of Splicing Factors as a Characteristic Feature of Intravenous Leiomyomatosis
    Lukáš Krásný, Christopher P. Wilding, Emma Perkins, Amani Arthur, Nafia Guljar, Andrew D. Jenks, Cyril Fisher, Ian Robert Judson, Khin Thway, Robin L. Jones et al. · 2022 · Cancers
73. VIPpred: a novel model for predicting variant impact on phosphorylation events driving carcinogenesis
    Xiaofeng Xu, Ying Li, Taoyu Chen, Chao Hou, Liang Yang, Peiyu Zhu, Yi Zhang, Tingting Li · 2023 · Briefings in Bioinformatics
74. Proteomics-based Model for Predicting the Risk of Brain Metastasis in Patients with Resected Lung Adenocarcinoma carrying the EGFR Mutation
    Qiuhua Deng, Fengnan Wang, Lei Song, Liang-Yü Chen, Ying Huang, Zhihua Guo, Haihong Yang · 2024 · International Journal of Medical Sciences
75. [LIM-domain binding protein 2 regulated by m6A modification inhibits lung adenocarcinoma cell proliferation in vitro].
    Dongfeng Zhai, G Wang, L Li, X Jia, Guili Zheng, J. A. Liu Yin · 2021 · PubMed Central
76. Adjuvant Therapy With EGFR Tyrosine Kinase Inhibitors: Tempering Great Expectations With Realism
    Saiama Naheed Waqar, Ramaswamy Govindan · 2021 · Journal of Clinical Oncology
77. A cellular and spatial atlas of TP53 -associated tissue remodeling in lung adenocarcinoma
    William Zhao, Benjamin Kepecs, Navin R. Mahadevan, Åsa Segerstolpe, Jason L. Weirather, Naomi R. Besson, Bruno Giotti, Brian Y. Soong, Chendi Li, Sébastien Vigneau et al. · 2023 · bioRxiv (Cold Spring Harbor Laboratory)
78. GPnotebook: A pan-cancer glycoproteomic database and toolkit for analysis of protein glycosylation changes associated with cancer phenotypes
    Hui Zhang, Yingwei Hu · 2024 · bioRxiv (Cold Spring Harbor Laboratory)
79. A hotspot phosphorylation site on SHP2 drives oncoprotein activation and drug resistance
    Karunaraj, Prashath, Scheele, Remkes, Wells, Malcolm L., Rathod, Ruchita, Gokulu, Ipek S., Abrahamson, Sophia R., Taylor, Lila, Chowdhury, Lamia, Kazmi, Abiha, Song, Weixiao et al. · 2026 · Nature Communications
80. Integrative multi-omics characterization of 12 syngeneic mouse models
    Zihan Xu, Binchen Mao, Hengyuan Liu, Shijia Wang, Xiaobo Chen, Sheng Jie Guo · 2025 · iScience
81. Murine models of lung adenocarcinoma: Valuable tools for preclinical investigation
    Wenli Shang, Caihong Lai, Shiwen Luo, Limin Chen · 2025 · Gene
82. Systems Biology-Based Drug Repositioning Identifies Extracellular Matrix Module as a Therapeutic Target in Lung Squamous Cell Carcinoma
    Bin Yang, Yuna Shao, Ziyun Zhou, Shuo Wang, Zeyi Liu, Guang Hu · 2025 · Journal of Medicinal Chemistry
83. Proteogenomic Characterization Reveals Metabolic Vulnerabilities and Aberrant Phosphorylation in Colorectal Metastasis to Liver
    Wensi Zhao, Lei Zhao, Yannan Lian, Zhiwei Liu, Yaqi Li, Xuege Wang, Mingya Zhang, Ni Li, Jingli Guo, Danqing Shen et al. · 2025 · Advanced Science
84. BDIViz: An Interactive Visualization System for Biomedical Schema Matching with LLM-Powered Validation
    Edward X. Wu, Dishita G Turakhia, Guande Wu, Christos Koutras, Sarah Keegan, Wenke Liu, Beáta Szeitz, David Fenyö, Claudio T. Silva, Juliana Freire · 2025 · IEEE Transactions on Visualization and Computer Graphics
85. A data-driven pan-cancer proteogenomic analysis reveals the characteristics of human cancer protein expression
    Ying Li, Clementine Xin Liu, Zhen Wang, Qiong Wu, Chulin Sha, Xiaolin Li · 2025 · iScience
86. Targeting thymine DNA glycosylase induces synthetic lethality in p53-deficient cancers
    Jiaxin Zhou, Zhenyu Shao, Lin Zhang, Jian-Nan Guo, Meng Wang, Qin Xu, Yi-Qin Wang, Qing Xu, Dan Zhou, Sheng-Xiang Ren et al. · 2026 · Nature Chemical Biology
87. Predicting and interpreting protein and phosphoprotein abundance from pan-cancer and single-cell transcriptomes
    Hui-Mei Tsai, Tzu‐Hung Hsiao, Yu‐Chiao Chiu, Yufei Huang, Eric Y. Chuang, Yidong Chen · 2026 · iScience
88. Upregulation of NDUFAF2 in Lung Adenocarcinoma Is a Novel Independent Prognostic Biomarker
    Kang Zou, Pengxiang Gao, Xinping Xu, Wei Zhang, Zhenguo Zeng · 2023 · Computational and Mathematical Methods in Medicine
89. Ephexin3/ARHGEF5 Together with Cell Migration Signaling Partners within the Tumor Microenvironment Define Prognostic Transcriptional Signatures in Multiple Cancer Types
    Dante Gustavo Juan-Guadarrama, Yarely Mabell Beltrán‐Navarro, Guadalupe Reyes‐Cruz, José Vázquez‐Prado · 2023 · International Journal of Molecular Sciences
90. Proteomic Analysis of Fractionated Eimeria tenella Sporulated Oocysts Reveals Involvement in Oocyst Wall Formation
    Liu-shu Jia, Qiping Zhao, Shunhai Zhu, Hongyu Han, Huanzhi Zhao, Yu Yu, Jia Ying Yang, Hui Dong · 2023 · International Journal of Molecular Sciences
91. MHD-Net: Memory-Aware Hetero-Modal Distillation Network for Thymic Epithelial Tumor Typing With Missing Pathology Modality
    Huaqi Zhang, Jie Liu, Weifan Liu, Huang Chen, Zekuan Yu, Yixuan Yuan, Pengyu Wang, Jing Qin · 2024 · IEEE Journal of Biomedical and Health Informatics
92. A liquid biopsy assay for the noninvasive detection of lymph node metastases in T1 lung adenocarcinoma
    Xin Li, Yang Gu, Bin Hu, Ming‐Ming Shao, Hui Li · 2024 · Thoracic Cancer
93. Proteomic features of soft tissue tumours in adolescents and young adults
    Yuen Bun Tam, Kaan Low, Hari PS, Madhumeeta Chadha, Jessica Burns, Christopher P. Wilding, Amani Arthur, Tom Wei‐Wu Chen, Khin Thway, Anguraj Sadanandam et al. · 2024 · Communications Medicine
94. Multi-Omics Characterization of E3 Regulatory Patterns in Different Cancer Types
    Zhongyan Li, Jingting Wan, Shangfu Li, Yun Tang, Yang-Chi-Dung Lin, Jie Ni, Xiaoxuan Cai, Jinhan Yu, Hsien‐Da Huang, Tzong-Yi Lee · 2024 · International Journal of Molecular Sciences
95. Decoding Ubiquitin Modifications by Mass Spectrometry
    Yanqiu Gong, Lunzhi Dai · 2024 · Advances in experimental medicine and biology
96. Cyclin-dependent kinases (CDKs) are key genes regulating early development of Neptunea arthritica cumingii: evidence from comparative transcriptome and proteome analyses
    Fengxiao Lv, Xinfan Ge, Yaqing Chang, Zhenlin Hao · 2024 · BMC Genomics
97. Advancements in proteogenomics for preclinical targeted cancer therapy research
    Yuying Suo, Yuanli Song, Yuqiu Wang, Qian Liu, Henry Rodriguez, Hu Zhou · 2025 · Biophysics Reports
98. In-Depth Proteomic Analysis of Tissue Interstitial Fluid Reveals Biomarker Candidates Related to Varying Differentiation Statuses in Gastric Adenocarcinoma
    Juxiang Zhang, An Xiong, Yuanyuan Yang, Yiou Cao, Mengxuan Yang, Chang Su, Ming Lei, Yi Chen, Xiaodong Shen, Pu‐Hua Wang et al. · 2025 · Journal of Proteome Research
99. A novel classification method for LUAD that guides personalized immunotherapy on the basis of the cross-talk of coagulation- and macrophage-related genes
    Zhuoqi Li, Ling Chen, Zhigang Wei, Hongtao Liu, Lu Zhang, Fujing Huang, Wen Xiao, Yuan Tian · 2025 · Frontiers in Immunology
100. Discovery of Key Candidate Protein Biomarkers in Early-Stage Nonsmall Cell Lung Carcinoma through Quantitative Proteomics
     Baby Rorielyn T. Dimayacyac-Esleta, Ferdinand D. Mira, Lorenzo M. Zarate, Ben Joshua O. Porras, Dave Laurence A. Juntilla, Lara Beatrice L. Suñga, Venus B. Pondevida, Sullian S. Naval, Treah May Sayo, Herdee Gloriane C. Luna et al. · 2025 · Journal of Proteome Research